Every Cure
The AI engine Fit Assessment
BetaEvery Cure effectively leverages machine learning to discover new drug-disease patterns and expand therapeutic options through drug repurposing.
Blurb
Every Cure is a nonprofit organization dedicated to unlocking the full potential of every existing medicine to treat every disease possible.
HQ Location
United States
Founded
2022
Employees
11 - 50
Total funding raised
$108.30M
Last Funding Event
Grant, $60.00M, October 9, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
Developer of an artificial intelligence (AI) medical technology designed to understand repurposed treatments. The company uses AI to identify promising drug repurposing opportunities and create a comprehensive drug repurposing database, structuring it as a biomedical knowledge graph, enabling healthcare professionals to treat their patients more optimally.